Ashland signs definitive agreement to sell nutraceuticals business to turnspire capital partners

Wilmington, del., may 07, 2024 (globe newswire) -- ashland inc. (nyse: ash) announced today that it has signed a definitive agreement to sell its nutraceuticals business to turnspire capital partners llc (“turnspire”). the transaction is expected to close in the calendar third quarter 2024, subject to the satisfaction of customary closing conditions.
ASH Ratings Summary
ASH Quant Ranking